Literature DB >> 7436538

Muscular changes in Engelmann's disease.

H Yoshioka, M Mino, N Kiyosawa, Y Hirasawa, Y Morikawa, Y Kasubuchi, T Kusunoki.   

Abstract

In a case of Engelmann's disease in an 11-year-old Japanese boy the muscular changes were studied in detail. Muscle weakness was maximal about the pelvic girdle. Muscle biopsy showed the selective atrophy of type II fibres, and no degenerative change could be seen histologically, histochemically, or electron-microscopically. Although the distribution of muscular weakness in Engelmann's disease is similar to that of a progressive muscular dystrophy, the disease does not seem to be a myopathy.

Entities:  

Mesh:

Year:  1980        PMID: 7436538      PMCID: PMC1626994          DOI: 10.1136/adc.55.9.716

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  5 in total

1.  PROGRESSIVE DIAPHYSEAL DYSPLASIA (ENGELMANN'S DISEASE).

Authors:  D K CLAWSON; J W LOOP
Journal:  J Bone Joint Surg Am       Date:  1964-01       Impact factor: 5.284

2.  Progessive diaphyseal dysplasia. Review of the literature and report of seven cases in one family.

Authors:  J D Hundley; F C Wilson
Journal:  J Bone Joint Surg Am       Date:  1973-04       Impact factor: 5.284

3.  Camurati-Engelmann disease. Genetics and clinical manifestations with a review of the literature.

Authors:  R S Sparkes; C B Graham
Journal:  J Med Genet       Date:  1972-03       Impact factor: 6.318

4.  Engelmann's disease. A case report.

Authors:  M F Yvars
Journal:  Clin Orthop Relat Res       Date:  1969 Jan-Feb       Impact factor: 4.176

5.  The histographic analysis of human muscle biopsies with regard to fiber types. 4. Children's biopsies.

Authors:  M H Brooke; W K Engel
Journal:  Neurology       Date:  1969-06       Impact factor: 9.910

  5 in total
  6 in total

1.  Vecuronium was safely used in a patient with Engelmann's disease without muscle weakness.

Authors:  Koji Sato; Maiko Nakajima; Tetsu Kimura; Toshiaki Nishikawa
Journal:  J Anesth       Date:  2012-01-15       Impact factor: 2.078

2.  Genetic mapping of the Camurati-Engelmann disease locus to chromosome 19q13.1-q13.3.

Authors:  M Ghadami; Y Makita; K Yoshida; G Nishimura; Y Fukushima; K Wakui; S Ikegawa; K Yamada; S Kondo; N Niikawa; H a Tomita
Journal:  Am J Hum Genet       Date:  2000-01       Impact factor: 11.025

Review 3.  Craniotubular bone disorders.

Authors:  R J Gorlin
Journal:  Pediatr Radiol       Date:  1994

4.  Skeletal dysplasias associated with mild myopathy-a clinical and molecular review.

Authors:  Katarzyna A Piróg; Michael D Briggs
Journal:  J Biomed Biotechnol       Date:  2010-05-24

5.  Orthopedic Manifestations of Type I Camurati-Engelmann Disease.

Authors:  Alisher J Yuldashev; Chang Ho Shin; Yong Sung Kim; Woo Young Jang; Moon Seok Park; Jong Hee Chae; Won Joon Yoo; In Ho Choi; Ok Hwa Kim; Tae-Joon Cho
Journal:  Clin Orthop Surg       Date:  2017-02-13

6.  New therapeutic targets in rare genetic skeletal diseases.

Authors:  Michael D Briggs; Peter A Bell; Michael J Wright; Katarzyna A Pirog
Journal:  Expert Opin Orphan Drugs       Date:  2015-09-24       Impact factor: 0.694

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.